Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test - Wikidata - wikimedia - TriplyDB

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

http://www.wikidata.org/entity/Q33870996

about

Genetic and epigenetic traits as biomarkers in colorectal cancer Epigenetics in diagnosis of colorectal cancer Vimentin DNA methylation predicts survival in breast cancer Genomic era diagnosis and management of hereditary and sporadic colon cancer.The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.Fecal molecular markers for colorectal cancer screening Aberrant methylation patterns in cancer: a clinical view.Comparative Correlation Structure of Colon Cancer Locus Specific Methylation: Characterisation of Patient Profiles and Potential Markers across 3 Array-Based Datasets.Mitochondrial A12308G alteration in tRNA(Leu(CUN)) in colorectal cancer samples.Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors.Current and emerging technology approaches in genomics Promoter CpG island methylation markers in colorectal cancer: the road ahead.DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.Genetic and epigenetic markers in colorectal cancer screening: recent advances.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels.Colorectal cancer: epigenetic alterations and their clinical implications.Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.

P2860

Q27016019-FDCB6B6B-B7C3-4DD8-83F2-F733BBBAF24F Q28071714-139B8ED7-F990-4B6D-8563-DABF589B90D0 Q34034767-A182C347-15AE-48FD-81E4-66693B3B789B Q34657586-8455D994-08AC-43A0-86B1-E3E38F336463 Q34776216-4CE9AEDA-850A-4263-B42B-67B514A051FC Q35152312-025EA2BB-E33D-481C-85FA-BB3098A32028 Q35579457-96762830-8BB6-4E0C-A2BA-C47C34F8A67B Q35750355-9C5A99FC-0B4B-4750-821F-FE7C2CCF6537 Q35856869-C4D09589-92BE-42AA-BDB6-45B8421669D3 Q35864177-4B1A9066-0862-41AD-9F41-F2EC3487A5F2 Q36044717-3C00F2F2-4476-44B6-B495-F06AB2DCF87A Q36272668-C24338B4-B466-482D-AE1F-374C8F91A039 Q36364067-460C2C4B-6BF4-485A-888A-22E5C82C150F Q36502335-297733B1-9A5D-42D6-A92A-837C81C226EF Q37172875-26F42958-45FD-482D-BE74-86D84AFC94A6 Q37997086-BB7AE8B4-8003-4B2C-A7BA-36799B35527C Q38140769-1A6790CC-DC97-4896-9C89-4AF817E4820B Q38676702-0223614E-400E-4E67-A159-C9380EC8DB1B Q38777365-91C53B0F-67D9-43DB-8D41-7C0281E2974A Q38783017-CF294166-655B-42C5-A3C1-6095ECE6A3F3 Q39030229-1EF78724-B955-4DC7-A17A-5C5827B76829 Q46112381-E7D8DD04-75AD-48E1-A0F0-69C2A5180615 Q55092089-B906F546-7941-43DC-9634-2FE0D80031B6

P2860

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

http://www.wikidata.org/entity/Q33870996

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@ast

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@en

type

label

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@ast

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@en

prefLabel

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@ast

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@en

P1433

Q33870996-F41F03FB-8DF7-42BF-9C47-088DED92AEB0

P1476

Q33870996-6123958F-DB11-4E22-824C-646275726B49

P2093

Q33870996-23016C3E-4615-4AD3-8E64-17BF13C3DF0C

Q33870996-EAE5253D-B88D-453D-B3D3-7E18C2E9E20A

P2860

Q33870996-1692AB60-4952-44AB-914E-87FE7C74972A

Q33870996-1E889159-4007-465F-8AD1-B642E64D6ED5

Q33870996-247AD70B-4557-43FC-989A-51D483AD2F20

Q33870996-40DE9491-96AB-488A-8522-9C79D01C49CF

Q33870996-51DCFBC7-4C7F-4FFB-99D5-59CB905558F3

Q33870996-5553776E-EFC0-4E3E-8494-0BD307A6A8E0

Q33870996-61EBCCEE-B771-4053-95B1-47E3B944C0FC

Q33870996-62A52E6D-3DEF-4F87-871B-45FA911071F4

Q33870996-779E9E9C-532F-40B2-9D5E-61018ED3DC00

Q33870996-7E9B5125-6989-420A-83EA-402C163DB9B3

P304

Q33870996-C313EE7B-44A2-40BB-A46A-52DD5BF2AA0B

P31

Q33870996-19A8F2D1-8420-4267-A36F-0DB7BB3351F6

P356

Q33870996-661D1A1D-F0E1-4C57-84E7-5C05B3957904

P478

Q33870996-FE9688A0-0FB3-474A-BE98-5BBCC4C2B6E4

P50

Q33870996-30A7A352-929C-4841-9C25-10932146F6A3

P577

Q33870996-E79039A1-30F8-46F9-9214-3DE780524278

P698

Q33870996-C596C784-14D5-41E5-87B6-02ECFF6D3BF7

P921

Q33870996-5AB118B1-4FDE-4809-9D41-71833956E005

Q33870996-686A90BC-6D46-4270-8320-8B72912D7091

P932

Q33870996-E8251DF1-C395-4C35-B55D-2C226EA40FB1

P356

CURRENTS.RRN1220

P1433

P1476

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

@en

P2093

Michael Marrone

http://www.w3.org/2001/XMLSchema#string

Renée M Ned

http://www.w3.org/2001/XMLSchema#string

P2860

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Empirical evidence of design-related bias in studies of diagnostic tests.

Patient perceptions of stool-based DNA testing for colorectal cancer screening.

Patient preferences for colorectal cancer screening: how does stool DNA testing fare?

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Systematic review: enhancing the use and quality of colorectal cancer screening.

Stool DNA and occult blood testing for screen detection of colorectal neoplasia

Sensitive digital quantification of DNA methylation in clinical samples.

P304

RRN1220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/CURRENTS.RRN1220

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie M. Melillo

P577

2011-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21487548

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3050633

http://www.w3.org/2001/XMLSchema#string